[
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome- a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med 23, 469–480, 2006.
]Search in Google Scholar
[
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645, 2009.
]Search in Google Scholar
[
Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A; AlkaMeSy Study Group. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33, 920–922, 2010.
]Search in Google Scholar
[
Aydin M, Bulur S, Alemdar R, Yalcin S, Turker Y, Basar C, Aslantas Y, Yazgan O, Albayrak S, Ozhan H, Melen Investigators. The impact of metabolic syndrome on carotid intima media thickness. Eur Rev Med Pharmacol Sci 17, 2295–2301, 2013.
]Search in Google Scholar
[
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Int Med 140, 167–174, 2004.
]Search in Google Scholar
[
Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Yang JY, Peng YS. Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients. Cardiovasc Diabetol 13, 136, 2014.
]Search in Google Scholar
[
Chiang JK, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord 12, 78, 2012.
]Search in Google Scholar
[
Evans PD, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One 7, e34699, 2012.
]Search in Google Scholar
[
Furuncuoglu Y, Tulgar S, Dogan AN, Cakar S, Tulgar YK, Cakiroglu B. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci 20, 1300–1306, 2016.
]Search in Google Scholar
[
Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 7, e52036, 2012.
]Search in Google Scholar
[
Gu Z, Zhu P, Wang Q, He H, Xu J, Zhang L, Li D, Wang J, Hu X, Ji G, Zhang L, Liu B. Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population. Lipids Health Dis 17, 289, 2018.
]Search in Google Scholar
[
Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol (Oxf) 81, 52–57, 2014.
]Search in Google Scholar
[
Hwang YC, Hayashi T, Fujimoto WY, Kahn SE, Leonetti DL, McNeely MJ, Boyko EJ. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes (Lond) 39, 1365–1370, 2015.
]Search in Google Scholar
[
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group 2013. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3, 1–150, 2013.
]Search in Google Scholar
[
Korea Ministry of Health and Welfare. Korean national health and nutrition examination survey. Sejong: Ministry of Health and Welfare. [cited 2019, March 14]. Available from: http://webcache.googleusercon-tent.com/search?q=cache:pHqT6158rPAJ:www.mohw.go.kr/react/modules/download.jsp%3FBOARD_ID%3D140%26CONT_SEQ%3D268137%26FILE_SEQ%3D102553+&cd=1&hl=ko&ct=clnk&gl=kr.
]Search in Google Scholar
[
Mazidi M, Kengne AP, Katsiki N, Mikhailidis DP, Banach M. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complications 32, 266–270, 2018.
]Search in Google Scholar
[
Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metabol 29, 443–449, 2014.
]Search in Google Scholar
[
Nikpayam O, Najafi M, Ghaffari S, Jafarabadi MA, Sohrab G, Roshanravan N. Effect of green coffee extract on fasting blood glucose, insulin concentration and homeostatic assessment of insulin resistance (HOMA IR): A systemic review and meta-analysis of interventional studies. Diabetol Metabol Syndrome 11, 91, 2019.
]Search in Google Scholar
[
Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab Syndr Relat Disord 16, 240–245, 2018.
]Search in Google Scholar
[
Ruan X, Guan Y. Metabolic syndrome and chronic kidney disease. J Diabetes 1, 236-245, 2009.
]Search in Google Scholar
[
Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414, 799–806, 2001.
]Search in Google Scholar
[
Song YM, Sung J, Lee K. Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study. Clin Exp Nephrol 19, 887–894, 2015.
]Search in Google Scholar
[
Taverna MJ, Martinez-Larrad MT, Frechtel GD, Serrano-Rios M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 164, 559–567, 2011.
]Search in Google Scholar
[
Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS, Joffe M, Nessel LA, Ojo A, Rader DJ, Reilly MP, Teal V, Teff K, Wright JT, Xie D. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol 33, 477–484, 2011.
]Search in Google Scholar
[
Zhou C, Zhan L, Yuan J, Tong X, Peng Y, Zha Y. Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients. Eat Weight Disord 25, 727–734, 2020.
]Search in Google Scholar
